Qtron Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,467
Closed -$503K 425
2025
Q2
$503K Buy
9,467
+1,892
+25% +$96.1K 0.06% 328
2025
Q1
$328K Sell
7,575
-2,087
-22% -$106K 0.05% 343
2024
Q4
$543K Hold
9,662
0.08% 306
2024
Q3
$658K Buy
+9,662
New +$545K 0.09% 291
2024
Q2
Sell
-4,097
Closed -$283K 471
2024
Q1
$283K Hold
4,097
0.04% 438
2023
Q4
$303K Buy
+4,097
New +$269K 0.05% 411
2022
Q2
Sell
-3,516
Closed -$246K 411
2022
Q1
$246K Buy
+3,516
New +$257K 0.06% 314
2021
Q2
Sell
-3,223
Closed -$425K 355
2021
Q1
$425K Buy
+3,223
New +$441K 0.12% 214

Other funds holding EXAS

Qtron Investments's EXAS Position: Q3 2025 in Review

Qtron Investments sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 9,467 shares — an estimated $503K sold.

Qtron Investments first reported a position in EXAS in Q1 2021 and held it in 8 quarters. The position peaked at $658K in Q3 2024. 569 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • Qtron Investments reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • Qtron Investments sold 9,467 Exact Sciences shares in Q3 2025, an estimated $503K.
  • Qtron Investments first reported a position in Exact Sciences in Q1 2021 and held it in 8 quarters.
  • Qtron Investments's Exact Sciences position peaked at $658K in Q3 2024.
  • 569 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on Qtron Investments's 13F filing for Q3 2025, filed 14 Nov 2025.